Closed · RFA-IP-11-003 · CFDA 93.185 · Discretionary
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Influenza in the United States
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- up to $785K
- Award range
- Closed
- Status
- March 1, 2011
- Close date
- 5
- Expected awards
The verdict
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Influenza in the United States is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $785,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.
- up to $785K
- award range
- Closed
- application status
- 5
- expected awards
- 93.185
- CFDA program
Archived opportunity record
Annual Estimates of Influenza Vaccine Effecti… is closed (last close March 1, 2011). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed March 1, 2011
Expected Awards
5
Instrument
Cooperative Agreement
Description
Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs. Estimating influenza vaccine effectiveness (VE) as soon as possible after the start of a seasonal influenza epidemic or pandemic and monitoring it over time will be essential in order to guide influenza vaccination and control policy. The populations to be studied will include those for whom CDC’s Advisory Committee on Immunization Practices recommends receipt of a licensed influenza vaccine. Influenza vaccination can prevent or reduce a number of outcomes, including laboratory-confirmed influenza virus infection, symptomatic illness given infection, severe illness and related complications due to influenza, the likelihood of transmitting the virus to others, or a combination of these. Thus, accurate estimation of vaccine effectiveness requires a multi-component approach, including accurate assessment of vaccination status, laboratory-confirmed disease outcomes, timing of illness and vaccination, and assessment of other factors that may affect vaccine use and immune response to vaccination. In addition, serological assessment of vaccine response and influenza antibody outcomes among vaccinated and unvaccinated individuals is also needed in order to understand vaccine response. Many additional factors can also affect the assessment of VE in observational studies such as the sensitivity and specificity of outcome measures, specimen collection methods, timing of vaccination, the setting for case and control recruitment, and the ratio of influenza illness to non-influenza respiratory illness. Moreover, a number of potential modifiers of vaccine response and vaccine effectiveness have been identified, including individual factors, environmental factors, and viral and infectious disease factors. Thus, applicants must describe plans to identify and control for a variety of potential confounders in each proposed analysis.
Catch-all / unrestricted eligibility mark · RFA-IP-11-003
Grants.gov marks Annual Estimates of Influenza Vaccine Effecti… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). 54 other Centers for Disease Control and Prevention - ERA listings share this eligibility-code string (8% of 640).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Technical Information and Managment Section (TIMS) Phone 770-488-2700
More from Centers for Disease Control and Prevention - ERA
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
What to do next
Annual Estimates of Influenza Vaccine Effecti… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.185 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |